Product Information
LACOSAMIDE 150 MG TABLET is a generic product labeled by Macleods Pharmaceuticals Limited, priced at $0.2127 per EA under NDC 33342030409. Its NADAC has been published 77 times since Mar 5, 2025.
FDA first approved this application on May 24, 2024. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
150 mg/1
Manufacturer
Macleods Pharmaceuticals LimitedNDC
33342030409
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
LACOSAMIDEApproval Type
Generic (ANDA)
FDA Application
ANDA208466FDA Approved
5/24/2024
TE Code
AB
On Market Since
5/24/2024
Pharmacological Classes
Price Statistics
The NADAC for LACOSAMIDE 150 MG TABLET has been published 77 times since Mar 5, 2025, and over the history we have for it it has declined 25.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2127 per EA |
|---|---|
| All-time high | $0.2890 (Apr 16, 2025) |
| All-time low | $0.2033 (Jul 22, 2026) |
| 52-week high | $0.2502 |
| 52-week low | $0.2033 |
| Median price | $0.2399 |
| Average price | $0.2414 |
| Largest weekly change | -7.2% (Jul 23, 2025) |
| Weeks tracked | 77 |
| Tracking since | Mar 5, 2025 |
Generic Alternatives
The matcher finds 8 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 3% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of LACOSAMIDE 150 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for LACOSAMIDE 150 MG TABLET, manufactured by Macleods Pharmaceuticals Limited, is $0.2127 per EA (NDC 33342030409), effective Aug 19, 2026.
How has the price of LACOSAMIDE 150 MG TABLET changed over time?
Over the history we have for it, the NADAC for LACOSAMIDE 150 MG TABLET has declined 25.5%. It has been tracked across 77 weekly CMS publications since Mar 5, 2025.
What are the highest and lowest recorded NADAC prices for LACOSAMIDE 150 MG TABLET?
Since Mar 5, 2025, the NADAC for LACOSAMIDE 150 MG TABLET has ranged from a low of $0.2033 (Jul 22, 2026) to a high of $0.2890 (Apr 16, 2025), with a median of $0.2399 per EA.
Are there cheaper alternatives to LACOSAMIDE 150 MG TABLET?
Yes. 8 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, LACOSAMIDE 150 MG TABLET, is $0.2069 per EA — about 3% below LACOSAMIDE 150 MG TABLET.
Who manufactures LACOSAMIDE 150 MG TABLET?
LACOSAMIDE 150 MG TABLET (NDC 33342030409) is labeled by Macleods Pharmaceuticals Limited, and CMS classifies it as a generic product.